Clement Larrue

Toulouse, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Targeting ferritinophagy to iron out Tet2-mutant cells.

Targeting ferritinophagy to iron out Tet2-mutant cells.

Journal: Blood
Published: September 04, 2025

Non-genetic remodeling drives leukemia propagation and reveals actionable vulnerabilities in acute myeloid leukemia.

Non-genetic remodeling drives leukemia propagation and reveals actionable vulnerabilities in acute myeloid leukemia.

Journal: Cell reports. Medicine
Published: June 20, 2025

Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia.

Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia.

Journal: Communications biology
Published: April 02, 2025

Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models.

Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models.

Journal: Science translational medicine
Published: July 24, 2024

The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia.

The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia.

Journal: Blood advances
Published: June 07, 2024

Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia.

Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia.

Journal: Blood advances
Published: October 12, 2023

Selective haematological cancer eradication with preserved haematopoiesis.

Selective haematological cancer eradication with preserved haematopoiesis.

Journal: Nature
Published: August 07, 2023

Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy.

Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy.

Journal: The Journal of experimental medicine
Published: July 17, 2023

CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia.

CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia.

Journal: Cancer research
Published: November 22, 2022

Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia.

Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia.

Journal: Leukemia
Published: October 11, 2022

C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant Leukemia.

C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant Leukemia.

Journal: Cancer discovery
Published: April 15, 2022

AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia.

AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia.

Journal: Cancers
Published: September 14, 2021
Showing 1-12 of 38

Last Updated: 09/26/2026